数亿元！人工智能数字化健康服务集团完成D轮融资

Core Insights - Huamei Haolian has completed a multi-hundred million RMB Series D financing round, led by Yifeng Capital, Yahui Long, Ventech China, and Fengqiao Capital, with participation from Dongfang Guozi, Jinsha River Ventures, and Tongji Alumni Fund. The funds will be used for clinical advancement and commercialization of core products [2]. Company Overview - Huamei Haolian Medical Technology (Beijing) Co., Ltd. was established in 2017, headquartered in Suzhou with an operational center in Beijing. The company positions itself as an AI digital health service technology group, providing health management service solutions covering the entire lifecycle from pre-diagnosis to post-diagnosis for clients in insurance, banking, and enterprises [3]. - The company has branches in multiple cities including Shanghai, Guangzhou, Hainan, Yinchuan, Hangzhou, and Hefei, as well as in the United States, serving nearly 300 B-end clients and covering over 56 million end users [3]. Product and Technology - The main products include AI intelligent applications, a medical service network, and an AI product system. The company has developed algorithms for "precise medical treatment" and "traditional Chinese medicine consultation," which have been officially filed in the precision medical field [8]. - The company has established a service network covering 1,650 top-tier hospitals nationwide and links with 8 international medical systems and 3,000 international experts [8]. - Diverse health management products include "AI General Practitioner," "AI Precise Medical Treatment," "AI Health Report Interpretation," and community healthcare assistants aimed at grassroots medical institutions [8]. Financing History - The financing history of Huamei Haolian includes several rounds, with the latest being a Series D round raising hundreds of millions of RMB. Previous rounds include a C+ round in September 2025 and a C round in July 2024, with various venture capital firms participating [9]. Patent Information - The company holds several patents, including a digital-based smart elderly care monitoring system and a smart medical response method based on big data, all of which have been authorized [10].